Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetes

Miyako KishimotoDepartment of Diabetes and Metabolic Medicine, Center Hospital, Tokyo, Japan; Diabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, JapanAbstract: Dipeptidyl peptidase-4 (DPP-4) inhibitors have recently emerged as...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Kishimoto M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/1f7f497fa7da4fc2b61b44b6f5d1ddd1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!